Want to join the conversation?
$SRCL expects 2016 revenue to be $3.6-3.66Bil. Internal growth rates are expected to be SQ, 7-9%; LQ, 4-7%; international, 6-9%; and recall and returns revenue $95-115MM. Free cash flow is expected to be $435-455MM and CapEx is expected to be $125-135MM in 2016.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?